FPH
FISHER & PAYKEL H. ORD FOR. EXEMPT NZXFisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.
FPH
FPH
FISHER & PAYKEL H. ORD FOR. EXEMPT NZX
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital.
Fundamentals
Historical Data63 days
| Date | Short % | Gross Short |
|---|---|---|
| 16 July | — | — |
| 15 July | — | — |
| 14 July | — | — |
| 13 July | 0.20% | — |
| 10 July | 0.19% | — |
| 9 July | 0.16% | — |
| 8 July | 0.16% | — |
| 7 July | 0.17% | — |
| 6 July | 0.16% | — |
| 3 July | 0.16% | — |
| 2 July | 0.17% | — |
| 1 July | 0.17% | — |
Fisher & Paykel H. Ord For. Exempt Nzx (FPH) Short Interest Summary
Fisher & Paykel H. Ord For. Exempt Nzx (FPH) currently has 0.20% of its shares sold short (1.2 million shares, worth approximately $38.2 million), based on ASIC short position data reported on 13 July 2026 (T+4 reporting lag). That makes FPH the #413 most shorted stock on the ASX most shorted list. Short interest in FPH is up 0.04% over the past week and down 0.09% over the past month. FPH is part of the Health Care sector on the ASX.
Recent FPH Short Position History
| Date | Short % | Short Shares | Close Price |
|---|---|---|---|
| 13 July 2026 | 0.20% | 1.2M | $33.15 |
| 10 July 2026 | 0.19% | 1.1M | $32.93 |
| 9 July 2026 | 0.16% | 0.9M | $33.01 |
| 8 July 2026 | 0.16% | 0.9M | $32.99 |
| 7 July 2026 | 0.17% | 1.0M | $33.49 |
| 6 July 2026 | 0.16% | 0.9M | $33.00 |
| 3 July 2026 | 0.16% | 0.9M | $32.74 |
| 2 July 2026 | 0.17% | 1.0M | $31.98 |
| 1 July 2026 | 0.17% | 1.0M | $31.81 |
| 30 June 2026 | 0.19% | 1.1M | $32.05 |
FPH Short Selling — Frequently Asked Questions
What is Fisher & Paykel H. Ord For. Exempt Nzx (FPH)'s current short interest?
Fisher & Paykel H. Ord For. Exempt Nzx (FPH) currently has a short interest of 0.20% of total shares outstanding. This means 0.20% of FPH's shares have been sold short by investors who expect the price to decline. This data is sourced from ASIC reports and updated daily.
Is FPH heavily shorted on the ASX?
FPH has a relatively low short interest of 0.20%. Short interest below 5% generally suggests limited bearish sentiment from short sellers.
What does short interest mean for FPH investors?
Short interest in FPH shows the percentage of shares investors have borrowed and sold, betting the price will fall. At 0.20%, FPH's short interest is at a low level. See our short squeeze candidates and days to cover analysis for more context.
Where does this FPH short data come from?
Short position data is published by ASIC with a four trading day delay (T+4) and covers reported short positions as a percentage of total shares on issue. ASX Short Data also tracks daily gross short sales (T+1), securities lending, and director trades for FPH.